British Journal of UrologyVolume 79, Issue S2 p. 64-68 Gene therapy for prostate cancer K. SIKORA PhD, FRCP, FRCR, Corresponding Author K. SIKORA PhD, FRCP, FRCR Professor of Clinical Oncology Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, UKDepartment of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK.Search for more papers by this authorH. PANDHA MRCP, FRACP, H. PANDHA MRCP, FRACP ICRF Clinical Research Fellow and Senior Registrar in Medical Oncology Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, UKSearch for more papers by this author K. SIKORA PhD, FRCP, FRCR, Corresponding Author K. SIKORA PhD, FRCP, FRCR Professor of Clinical Oncology Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, UKDepartment of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK.Search for more papers by this authorH. PANDHA MRCP, FRACP, H. PANDHA MRCP, FRACP ICRF Clinical Research Fellow and Senior Registrar in Medical Oncology Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London, UKSearch for more papers by this author First published: 16 September 2010 https://doi.org/10.1111/j.1464-410X.1997.tb16923.xCitations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume79, IssueS2April 1997Pages 64-68 RelatedInformation